ACS Bio & Med Chem Au

Scope & Guideline

Advancing the frontiers of biochemistry and medicinal chemistry.

Introduction

Explore the comprehensive scope of ACS Bio & Med Chem Au through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore ACS Bio & Med Chem Au in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherAMER CHEMICAL SOC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationACS BIO MED CHEM AU / ACS Bio Med Chem Au
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1155 16TH ST, NW, WASHINGTON, DC 20036

Aims and Scopes

The journal "ACS Bio & Med Chem Au" serves as a platform for the dissemination of innovative research in the fields of biological and medicinal chemistry. Its primary focus lies in the intersection of chemistry and biological sciences, emphasizing the design, synthesis, and evaluation of chemical compounds with biological significance.
  1. Biological Chemistry and Drug Design:
    The journal emphasizes the design and synthesis of biologically active compounds, including small molecules and peptides, aimed at therapeutic applications.
  2. Catalysis and Mechanistic Studies:
    Research on catalytic mechanisms and the role of enzymes in biological processes is a core theme, including investigations into RNase families and protease inhibitors.
  3. Biotechnology and Bioengineering:
    The journal publishes studies on biotechnological applications, such as the development of bioproduction platforms and functionalized biomaterials for medical use.
  4. Structural Biology and Imaging Techniques:
    Studies utilizing advanced imaging techniques and structural biology to elucidate the interactions of biomolecules and their mechanisms of action are prominently featured.
  5. Nanotechnology and Biomaterials:
    Research on the development of nanocarriers and materials for drug delivery, as well as the exploration of their biological interactions, is a significant focus area.
  6. Bioinformatics and Computational Chemistry:
    The integration of computational methods to understand biological processes and predict the interactions of compounds with biological targets is a growing area of interest.
The journal has shown a dynamic evolution in its focus areas, with certain themes gaining traction in recent publications. These emerging topics reflect current challenges and innovations in the fields of bio and medicinal chemistry.
  1. Targeted Protein Degradation:
    Research on targeted protein degradation techniques, such as the use of heterobifunctional degraders, is on the rise, reflecting a growing interest in innovative therapeutic strategies.
  2. Synthetic Biology and Bioconjugation:
    There is an increasing trend in studies involving synthetic biology approaches, particularly in the design and engineering of peptide ligands and bioconjugates for therapeutic applications.
  3. Immunotherapy and Antibody Development:
    The journal has seen a surge in papers focused on immunotherapeutic strategies, including the development of antibody-based therapies and their mechanisms of action.
  4. Antiviral Agents and COVID-19 Research:
    In light of the recent pandemic, there is a notable increase in research related to antiviral agents and their mechanisms, particularly studies aimed at combating SARS-CoV-2.
  5. Nanomedicine and Drug Delivery Systems:
    Emerging themes in nanomedicine, particularly regarding the development of nanocarriers for drug delivery and their interactions in biological systems, are increasingly prevalent.

Declining or Waning

While the journal has consistently explored various themes over the years, certain areas of research have shown a decline in prominence. This could reflect broader trends in the scientific community or shifts in research funding and interest.
  1. Traditional Antibiotics and Resistance Mechanisms:
    Research focused on traditional antibiotics and their mechanisms of action appears to be waning, possibly due to the shift towards exploring novel antimicrobial strategies and resistance mechanisms.
  2. Basic Biochemical Pathways:
    There has been a noticeable decline in publications centered on fundamental biochemical pathways, as the journal shifts towards more applied research with immediate clinical implications.
  3. Natural Products Chemistry:
    The exploration of natural products as a source of therapeutic agents seems to be less frequent, possibly overshadowed by synthetic and engineered compounds with targeted actions.
  4. General Reviews on Established Topics:
    The publication of broad review articles on well-established topics is decreasing, indicating a preference for more specialized and cutting-edge reviews that focus on emerging areas.

Similar Journals

CHEMICAL RECORD

Empowering Scholars with Impactful Chemical Discoveries
Publisher: WILEY-V C H VERLAG GMBHISSN: 1527-8999Frequency: 12 issues/year

The Chemical Record is a prestigious peer-reviewed journal published by WILEY-V C H VERLAG GMBH, focusing on innovative research and developments across the diverse and evolving fields of chemistry and biochemistry. With an esteemed 2023 Impact Factor and recognized as a Q1 journal in several categories—including Biochemistry, Chemical Engineering, and Materials Chemistry—The Chemical Record stands as a critical resource for researchers, professionals, and students aiming to disseminate and acquire knowledge in these disciplines. The journal's engaging scope covers contemporary topics and fosters collaboration within the global scientific community, ensuring accessibility to cutting-edge research. By publishing articles that meet the highest standards of scholarship, it has earned a significant place within the academic ecosystem, as reflected in its strong Scopus rankings. Although The Chemical Record operates without open access, it remains deeply committed to advancing the field of chemistry through rigorous and impactful publications that bridge gaps between theory and practice.

Doklady Biochemistry and Biophysics

Bridging Knowledge Gaps in Biochemical and Biophysical Sciences
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1607-6729Frequency: 6 issues/year

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

BIOORGANIC CHEMISTRY

Catalyzing advancements in drug discovery and biochemistry.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0045-2068Frequency: 12 issues/year

BIOORGANIC CHEMISTRY, published by Academic Press Inc., a prestigious imprint of Elsevier Science, represents a cornerstone in the fields of biochemistry, organic chemistry, and drug discovery. With an impressive Scopus rank placing it in the top quartiles across critical categories—including Q2 for Biochemistry and Drug Discovery, and Q1 for Organic Chemistry—this journal has established itself as a vital resource for researchers, professionals, and students alike. Featuring a diverse array of articles that explore innovative methodologies and emerging trends from 1971 to the present, BIOORGANIC CHEMISTRY effectively bridges the gap between laboratory research and practical applications. Although not an Open Access journal, its rigorous peer-review process ensures the delivery of high-quality, impactful research that drives advances in the understanding and application of biochemistry. With an aim to facilitate scientific discourse and collaboration, it invites contributions that further the exploration of chemical processes within biological systems.

Future Medicinal Chemistry

Connecting researchers to the future of medicine.
Publisher: Newlands Press LtdISSN: 1756-8919Frequency: 24 issues/year

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.

RSC Medicinal Chemistry

Catalyzing Change in Drug Discovery and Development
Publisher: ROYAL SOC CHEMISTRYISSN: Frequency: 12 issues/year

RSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.

ChemPlusChem

Advancing Chemistry Through Collaboration and Innovation
Publisher: WILEY-V C H VERLAG GMBHISSN: 2192-6506Frequency: 12 issues/year

ChemPlusChem is a premier journal published by WILEY-V C H VERLAG GMBH, dedicated to the vibrant field of chemistry. With an ISSN of 2192-6506 and an impressive Q1 ranking in Scopus's 2023 category for miscellaneous chemistry, this journal serves as a significant platform for the dissemination of high-quality research and innovative findings. Since its inception in 2012, ChemPlusChem has fostered interdisciplinary collaborations, encapsulating a wide array of topics within chemistry that facilitate scientific advancement and education. The journal features a robust open access system, enabling extensive visibility for authors while providing easy-to-access resources for researchers, professionals, and students globally. Located in Weinheim, Germany, ChemPlusChem reflects international standards and ambitions, striving to enrich the global scientific community through rigorous research and engaging scientific discourse.

Peptide Science

Unlocking the potential of peptides in science.
Publisher: WILEYISSN: 2475-8817Frequency: 6 issues/year

Peptide Science, published by Wiley, is an esteemed journal dedicated to advancing the understanding of peptide chemistry and its applications across various scientific disciplines, including biochemistry, biophysics, and organic chemistry. Since its inception in 2018 and continuing through 2024, this journal has provided an essential platform for the dissemination of innovative research, engaging articles, and critical reviews. With an impressive Q3 ranking in the fields of Biochemistry and Biomaterials, and a Q2 status in Biophysics and Organic Chemistry as of 2023, Peptide Science acknowledges its integral role in addressing significant scientific challenges. This open-access journal ensures that findings are readily available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. The journal exemplifies excellence in scholarly communication, making it an essential resource for anyone interested in the intricate world of peptide research.

Chemical Biology & Drug Design

Fostering breakthroughs in molecular medicine and drug design.
Publisher: WILEYISSN: 1747-0277Frequency: 12 issues/year

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY

Empowering Researchers with Peer-Reviewed Excellence
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1068-1620Frequency: 7 issues/year

Russian Journal of Bioorganic Chemistry (ISSN: 1068-1620, E-ISSN: 1608-330X), published by MAIK Nauka/Interperiodica/Springer, serves as a vital resource for researchers and professionals in the fields of bioorganic chemistry, biochemistry, and organic chemistry. With a focus on the integration of organic chemistry principles with biological processes, this journal aims to disseminate significant findings and advancements from both theoretical and practical perspectives. Although currently not open access, the journal retains a dedication to high-quality, peer-reviewed content, contributing to its reputation within the academic community. The 2023 Scopus rankings position it within the Q4 category for both biochemistry and organic chemistry, indicating its critical niche within these disciplines amid a competitive landscape. Since its inception in 1996, the journal has continued to evolve, providing enriching insights and fostering collaborations among scholars and practitioners alike, with publication converging up to the year 2024. By exploring complex biomolecular interactions and the synthesis of biologically relevant compounds, the Russian Journal of Bioorganic Chemistry remains a significant platform for advancing knowledge and innovation in the life sciences.

MONATSHEFTE FUR CHEMIE

Fostering Innovation Through a Historic Lens on Chemistry
Publisher: SPRINGER WIENISSN: 0026-9247Frequency: 12 issues/year

MONATSHEFTE FUR CHEMIE, an esteemed journal published by Springer Wien, has been a significant contributor to the field of chemistry since its inception in the late 19th century. With a rich history spanning from 1880 to the present, this journal provides a platform for innovative research and comprehensive reviews in various areas of general chemistry. Although it currently holds a Q3 ranking in the miscellaneous category of chemistry, its commitment to maintaining high academic standards is reflected in its continued relevance and citation impact, as evidenced by its Scopus ranking. Researchers, professionals, and students engaged in chemical sciences will find this journal a valuable resource for advancing their knowledge and contributing to ongoing discussions in the field. For those looking to stay updated on the latest developments in chemistry while engaging with a storied publication, MONATSHEFTE FUR CHEMIE is a pivotal source of insightful content.